Comment on

• Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.

  Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P. Schenk D, et al. Nature. 1999 Jul 8;400(6740):173-7. doi: 10.1038/22124. Nature. 1999. PMID: 10408445
• A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.

  Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, Chishti MA, Horne P, Heslin D, French J, Mount HT, Nixon RA, Mercken M, Bergeron C, Fraser PE, St George-Hyslop P, Westaway D. Janus C, et al. Nature. 2000 Dec 21-28;408(6815):979-82. doi: 10.1038/35050110. Nature. 2000. PMID: 11140685
• A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.

  Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope C, Gordon M, Arendash GW. Morgan D, et al. Nature. 2000 Dec 21-28;408(6815):982-5. doi: 10.1038/35050116. Nature. 2000. PMID: 11140686
• Nerve inflammation halts trial for Alzheimer's drug.

  Check E. Check E. Nature. 2002 Jan 31;415(6871):462. doi: 10.1038/415462a. Nature. 2002. PMID: 11823817 No abstract available.